Literature DB >> 18561863

Therapeutic immunomodulators from nematode parasites.

William Harnett1, Margaret M Harnett.   

Abstract

There has been an alarming increase in the incidence of autoimmune and allergic diseases in Western countries in the past few decades. However, in countries endemic for parasitic helminth infections, such diseases remain relatively rare. Hence, it has been hypothesised that helminths may protect against the development of autoimmunity and allergy. This article reviews the evidence supporting this idea with respect to helminths of the phylum Nematoda (nematodes), considering data from human studies and animal models of inflammatory disease. The nature and mode of action of nematode-derived molecules with immunomodulatory properties are considered, and their therapeutic efficacy in models of autoimmunity and allergy described. The recent and future use of nematodes and their products in treating human disease are also discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18561863     DOI: 10.1017/S1462399408000720

Source DB:  PubMed          Journal:  Expert Rev Mol Med        ISSN: 1462-3994            Impact factor:   5.600


  17 in total

Review 1.  Helminth-derived immunomodulators: can understanding the worm produce the pill?

Authors:  William Harnett; Margaret M Harnett
Journal:  Nat Rev Immunol       Date:  2010-03-12       Impact factor: 53.106

2.  Helminth protection against autoimmune diabetes in nonobese diabetic mice is independent of a type 2 immune shift and requires TGF-β.

Authors:  Marc P Hübner; Yinghui Shi; Marina N Torrero; Ellen Mueller; David Larson; Kateryna Soloviova; Fabian Gondorf; Achim Hoerauf; Kristin E Killoran; J Thomas Stocker; Stephen J Davies; Kristin V Tarbell; Edward Mitre
Journal:  J Immunol       Date:  2011-12-14       Impact factor: 5.422

3.  The therapeutic potential of the filarial nematode-derived immunodulator, ES-62 in inflammatory disease.

Authors:  M M Harnett; A J Melendez; W Harnett
Journal:  Clin Exp Immunol       Date:  2009-12-01       Impact factor: 4.330

4.  Suppression of type 2 immunity and allergic airway inflammation by secreted products of the helminth Heligmosomoides polygyrus.

Authors:  Henry J McSorley; Mary T O'Gorman; Natalie Blair; Tara E Sutherland; Kara J Filbey; Rick M Maizels
Journal:  Eur J Immunol       Date:  2012-08-08       Impact factor: 5.532

5.  Proteomic analysis of secretory products from the model gastrointestinal nematode Heligmosomoides polygyrus reveals dominance of venom allergen-like (VAL) proteins.

Authors:  James P Hewitson; Yvonne Harcus; Janice Murray; Maaike van Agtmaal; Kara J Filbey; John R Grainger; Stephen Bridgett; Mark L Blaxter; Peter D Ashton; David A Ashford; Rachel S Curwen; R Alan Wilson; Adam A Dowle; Rick M Maizels
Journal:  J Proteomics       Date:  2011-06-29       Impact factor: 4.044

6.  First analysis of the secretome of the canine heartworm, Dirofilaria immitis.

Authors:  James Geary; Mohamed Satti; Yovany Moreno; Nicole Madrill; Doug Whitten; Selwyn A Headley; Dalen Agnew; Timothy Geary; Charles Mackenzie
Journal:  Parasit Vectors       Date:  2012-07-10       Impact factor: 3.876

7.  Crude extracts of Caenorhabditis elegans suppress airway inflammation in a murine model of allergic asthma.

Authors:  Sung Eun Kim; Jae-Hwan Kim; Byung-Hoon Min; Young Mee Bae; Sung-Tae Hong; Min-Ho Choi
Journal:  PLoS One       Date:  2012-04-25       Impact factor: 3.240

Review 8.  Helminth immunoregulation: the role of parasite secreted proteins in modulating host immunity.

Authors:  James P Hewitson; John R Grainger; Rick M Maizels
Journal:  Mol Biochem Parasitol       Date:  2009-05-03       Impact factor: 1.759

Review 9.  Helminth genomics: The implications for human health.

Authors:  Paul J Brindley; Makedonka Mitreva; Elodie Ghedin; Sara Lustigman
Journal:  PLoS Negl Trop Dis       Date:  2009-10-26

Review 10.  Regulation of pathogenesis and immunity in helminth infections.

Authors:  Rick M Maizels; Edward J Pearce; David Artis; Maria Yazdanbakhsh; Thomas A Wynn
Journal:  J Exp Med       Date:  2009-09-21       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.